This inventor holds 3 USPTO granted patents. Top assignee: Vical Incorporated. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: Nancy Horn: Innovator in Biopharmaceutical Purification
Introduction
Nancy Horn is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the purification of plasmid DNA and the reduction of RNA concentration in biological mixtures. With a total of 3 patents, her work has paved the way for advancements in biopharmaceutical manufacturing.
Latest Patents
One of Nancy's latest patents is titled "Purification of plasmid DNA during column chromatography." This invention provides a method for purifying plasmid DNA by adding a short chain polymeric alcohol, preferably polyethylene glycol, to a DNA sample before column chromatography. This process enhances the isolation of plasmid DNA and is particularly useful for large-scale purification in biopharmaceutical manufacturing.
Another significant patent is the "Process for reducing RNA concentration in a mixture of biological material." This invention outlines a method that involves filtering a biological mixture through diatomaceous earth material to reduce RNA concentration. The steps include providing a mixture with a first concentration of RNA, filtering it to produce a filtrate with a lower RNA concentration, and collecting the filtrate for further use.
Career Highlights
Nancy Horn is currently associated with Vical Incorporated, where she continues to innovate in the field of biopharmaceuticals. Her work has been instrumental in developing methods that enhance the efficiency and effectiveness of biopharmaceutical production.
Collaborations
Nancy collaborates with talented professionals in her field, including Magda Marquet and Jennifer Meek. Their combined expertise contributes to the advancement of biopharmaceutical technologies.
Conclusion
Nancy Horn's contributions to the field of biopharmaceutical purification are noteworthy. Her innovative patents and collaborations reflect her commitment to advancing biopharmaceutical manufacturing processes. Her work continues to impact the industry positively.